Virtu Financial LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$239,000
-54.4%
22,232
-65.6%
0.02%
-72.1%
Q2 2020$524,000
+3393.3%
64,711
+338.0%
0.06%
+6000.0%
Q4 2019$15,000
+36.4%
14,774
-57.8%
0.00%0.0%
Q3 2019$11,000
+83.3%
34,991
+79.0%
0.00%
Q2 2019$6,000
-68.4%
19,548
+77.2%
0.00%
-100.0%
Q4 2018$19,000
-86.8%
11,029
-44.6%
0.00%
-87.5%
Q4 2017$144,00019,8980.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders